×
ADVERTISEMENT

migraine

Study Shows Atogepant Prevents Migraine In Difficult Cases

A recent study has shown that atogepant (Qulipta, AbbVie), may help prevent migraines in people who have had no ...

SEPTEMBER 2, 2023

Post-op Delirium Lower in Patients With Pre-op Migraine Diagnosis

A preoperative diagnosis of migraine is associated with less postoperative delirium, a surprising finding from a ...

OCTOBER 28, 2022

Intranasal Ketamine May Offer Relief for Headache Patients Who Have Exhausted Other Options

Intranasal ketamine is emerging as a clinical tool to address pain caused by chronic refractory migraine.

MAY 14, 2022

Cannabis for Migraine Associated With Rebound Headache

Using cannabis to relieve migraine headache may be linked with developing “rebound” headache, or ...

JULY 11, 2021

FDA Clears Remote Electrical Neuromodulation Device for Younger Patients

The FDA cleared a remote electrical neuromodulation device for acute treatment of episodic or chronic migraine ...

FEBRUARY 9, 2021

FDA Approves New Preventive Injection for Migraine

The FDA approved the first preventive injection for migraine, erenumab-aooe (Aimovig, Amgen), a once-monthly ...

MAY 30, 2018

Opioid Abuse Fix: Just Say No?

Clinicians should think twice when prescribing opioids to patients for the first time to relieve pain, migraines or ...

OCTOBER 30, 2016

Load more